Under-reporting of adverse drug reactions in general practice
about
The counterfeit anti-malarial is a crime against humanity: a systematic review of the scientific evidencePerception of the risk of adverse drug reactions: differences between health professionals and non health professionalsComparison of two drug safety signals in a pharmacovigilance data mining framework.Educational sessions in pharmacovigilance: What do the doctors think?Bisphosphonate-related osteonecrosis of the jaw: data from the French national pharmacovigilance database.Is there still a role for spontaneous reporting of adverse drug reactions?Patient safety: what about the patient?Results from a nationwide postmarketing cohort study of patients in Sweden treated with etanercept.Spontaneously reported hepatic adverse drug events in Korea: multicenter study.Role of Pharmacovigilance in India: An overview.Veterinary pharmacovigilance. Part 2. Veterinary pharmacovigilance in practice -- the operation of a spontaneous reporting scheme in a European Union country -- the UK, and schemes in other countries.Adverse events associated with paediatric use of complementary and alternative medicine: Results of a Canadian Paediatric Surveillance Program surveyEstimating time-to-onset of adverse drug reactions from spontaneous reporting databases.Increasing the number of adverse drug reactions reporting: the role of clinical pharmacy residents.Initiatives to identify and mitigate medication errors in England.Clozapine-Induced Gastrointestinal Hypomotility: A 22-Year Bi-National Pharmacovigilance Study of Serious or Fatal 'Slow Gut' Reactions, and Comparison with International Drug Safety Advice.Methods for safety signal detection in healthcare databases: a literature review.Empirical estimation of under-reporting in the U.S. Food and Drug Administration Adverse Event Reporting System (FAERS).The past, present and perhaps future of pharmacovigilance: homage to Folke Sjoqvist.The Incidence of Drug- and Herbal and Dietary Supplement-Induced Liver Injury: Preliminary Findings from Gastroenterologist-Based Surveillance in the Population of the State of Delaware.Illicit drugs or medicines taken by parachuting.Fluindione and drug reaction with eosinophilia and systemic symptoms: an unrecognised adverse effect?Knowledge, attitude and perception/practices (KAP) of medical practitioners in India towards adverse drug reaction (ADR) reporting.Patient-reporting of side effects may provide an important source of information in clinical practice.Drug safety without borders: concerns about bupropion.Adverse event reporting for herbal medicines: a result of market forces.A 10-year survey of inflammatory bowel diseases-drug therapy, costs and adverse reactions.Pilot evaluation of an automated method to decrease false-positive signals induced by co-prescriptions in spontaneous reporting databases.Complications of BCG vaccine SSI® recent story and risk management plan: the French experience.Underreporting of recognized adverse drug reactions by primary care physicians: an exploratory study.Safety of herbal products in Thailand: an analysis of reports in the thai health product vigilance center database from 2000 to 2008.Identification of abuse and dependence cases through a hospital database.Clinical perspectives in drug safety and adverse drug reactions.Assessment of the state of pharmacovigilance in the South-South zone of Nigeria using WHO pharmacovigilance indicators.Integrated Pharmacovigilance System for CM-Induced Adverse Reactions. Sistema di farmacovigilanza integrata per le reazioni avverse
P2860
Q26828002-C65D8021-1B7D-461E-8041-B85366476FD7Q28194005-EA77EC85-4FE1-44F0-9D6A-796C0A6F0ED6Q30573571-67464154-3F40-4F2F-A779-039291E46C40Q30992133-C12C19B2-5C4A-4B60-AE6F-D4683D5336A4Q31108809-97704859-4821-4999-A78E-729AABC836ADQ34257364-AF4B9B9D-289C-47BE-AAF1-E6BFE1D6B783Q35524666-BCFA6F3C-9D4A-43F8-8E5C-C1F04545043CQ35555131-E35B4C00-2491-4BD0-A2C6-3FC25BC84265Q35778423-D1F9DBFF-4BEE-47C4-84AF-89EEDD443964Q36077051-86AD0AC7-5C1E-4F36-9753-65A87763E354Q36103055-EF8F9B95-DB1F-4C8C-A940-680F6D0DC091Q37326985-A7A5E142-DB40-4A93-9A51-B821F82A0E6CQ37581719-6193C1F1-9D2D-40E3-A74A-586093C6C953Q37700678-01A017CD-97A2-4498-B7F9-BFF6FDB856FDQ38367281-0BC2F6F9-2457-4B65-9B57-BC11FCCB5F96Q38721556-C2F3117F-B888-4840-943E-8E37286B345AQ38793916-A0B56897-E389-4657-BC11-11820481F8FDQ38817615-ADB7AC58-EA8B-4A69-B56E-D4F7AFF8FA21Q39422837-E8460031-602B-43EA-9926-AFDF084882B0Q40181580-D0FD93DC-946E-46CC-82F9-CBBE884C1F1CQ40272032-559376FB-33DB-4F30-9640-A3375924E2FCQ40317166-ED1EEA11-027A-4B8C-BCF3-4C0D6938FC0AQ41548633-11858067-C5E4-4743-B5BA-8B7E123961BCQ42609701-B30A606A-65D1-4FD4-B3DC-22A7BCF4F839Q42771620-2F9C21FD-EA75-4413-BDF0-72E6DD36C8D5Q43107373-C399FDC1-1625-4764-84D2-A574171A5B88Q43563780-0C70B29A-F457-4201-B84B-DFB3BC7A4870Q44428648-3E095C41-D2D8-4D38-96E6-81F125C1818CQ44608649-2CC6C1A0-E617-41B5-8341-DF34382F1528Q45113251-CAAAEEAF-CE15-4F44-A737-7AFB4AD17395Q46059701-D23AC711-39CB-43CB-85F0-237F090AC7BAQ46219824-A4D7A210-54C8-404F-89AD-0953AE3C593CQ46975372-7C657DBA-E226-473D-8A45-A6E231C8863CQ55188503-61F50F7B-CF44-4DA5-A08F-96FE799C7916Q56990321-FB2051E0-721F-485F-AB2E-399AF7C87365
P2860
Under-reporting of adverse drug reactions in general practice
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Under-reporting of adverse drug reactions in general practice
@ast
Under-reporting of adverse drug reactions in general practice
@en
type
label
Under-reporting of adverse drug reactions in general practice
@ast
Under-reporting of adverse drug reactions in general practice
@en
prefLabel
Under-reporting of adverse drug reactions in general practice
@ast
Under-reporting of adverse drug reactions in general practice
@en
P2093
P1476
Under-reporting of adverse drug reactions in general practice
@en
P2093
P304
P356
10.1046/J.1365-2125.1997.05417.X
P407
P577
1997-02-01T00:00:00Z